Last Updated on December 16, 2022 by The Health Master
The US district court in Florida dismissed almost 2,500 lawsuits alleging links between the heartburn medication Zantac (ranitidine) and cancer.
The judge said that almost 2,500 lawsuits filed in federal court by plaintiffs were based on flawed science and that the only reliable testing of the blockbuster drug undertaken showed an ‘unprovable risk of cancer.’
The recent decision of the US district court to slap down the long-pending cancer litigation over Zantac (ranitidine) has assured that science prevails over propaganda.
The ruling has dismissed thousands of lawsuits, saying that no science-driven, sound scientific evidence establishes a link between Zantac and cancer.
The ruling concludes that consumers used flawed science to back up lawsuits filed in federal court blaming Zantac for causing a variety of cancers.
The experts couldn’t show legitimate links between the product and the diseases, which include lung, liver, and kidney cancer.
Moreover, in India, when the National List of Essential Medicines (NLEM) dropped 26 medicines from the list, including Zantac (ranitidine), the government officials clarified that there are no side-effects, but other parameters like cost-effectiveness and availability of better drugs were the reasons for the drugs to be taken off the NLEM list.
Molecules like atenolol, erythromycin, ranitidine, and many more that are out of NLEM have been safe and efficacious for more than four decades.
There are no side effects or cancer concerns with these molecules as recently stated in international studies as well.
The ruling was a significant win for the pharma companies GSK, Pfizer, Sanofi, and Boehringer Ingelheim.
USFDA approves this lung cancer drug
International drug racket busted in Hyderabad, two held
Drug alert: 83 out of 1487 samples declared as NSQ in November 20222
FDA: Patients cannot be forced to buy medicines from hospital-attached pharmacies
Pharmacy education needs to adopt 2D, 3D format for lectures
Indian Pharma Companies have potential in Saudi Arabia
USFDA gives nod for Silodosin, Pregabalin Capsules
Parliament panel recommendation for National Commission on Medical Devices
Homoeopathy: Commission notifies BHMS Regulations 2022
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
